Tech Company Financing Transactions
Somagenetix Funding Round
Somagenetix, based in Zurich, raised $11.8 million in funding from VI Partners, Schroders Capital and Verve Ventures.
Transaction Overview
Company Name
Announced On
10/9/2024
Transaction Type
Venture Equity
Amount
$11,800,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to advance its leading gene therapy-candidate, SGX-001.
Company Information
Company Status
Private & Independent
Industry
Manufacturing
Mailing Address
In der Breiti 2
Zurich, 8047
Switzerland
Zurich, 8047
Switzerland
Phone
Undisclosed
Website
Email Address
Overview
Our platform utilizes lentivirus-transduced stem cells to offer safe and effective therapies for potentially more than 50 known genetic disorders. The specific safety of our one-time treatment lies in its exclusive activity within terminally differentiated cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrin Oswald
Browse more venture capital transactions:
Prev: 10/9/2024: EvenUp venture capital transaction
Next: 10/9/2024: Babson Diagnostics venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs